Half-year Report

AI SummaryClose X

Surgical Innovations Group plc reported interim results for the six months ended 30 June 2026, with revenues remaining broadly flat at £6.02 million compared to £6.15 million in the prior year. The company experienced a decrease in adjusted EBITDA profit to £0.03 million from £0.37 million in H1 2025, while gross profit margin stood at 29.0%, down from 31.2% in the previous year but up from FY 2025's 26.3%. Net debt remained stable at £0.3 million, with £0.2 million headroom under the invoice financing facility. Despite trading headwinds in certain markets, particularly the US, the company anticipates a return to growth in H2 2026 driven by new third-party products and an investment in its UK sales team.

Disclaimer*

UK 100

Latest directors dealings